Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Combined Military Hospital Abbottabad

ClinicalTrials.gov lists Combined Military Hospital Abbottabad as lead sponsor of 25 trials. It has 28 active development programs and 10 approved assets.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 17 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Active development programs Active development programs 28 Approved assets Approved assets 10 Journals published in Journals published in 13 Latest dated events Latest dated events 26 Disease areas Disease areas 17 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Active development programs Active development programs 28 Approved assets Approved assets 10 Journals published in Journals published in 13 Latest dated events Latest dated events 26

Rows recorded per section

18 sections measured, none recorded

This page covers Combined Military Hospital Abbottabad: 25 lead-sponsored trials and 0 legal-entity registrations.

Get the Combined Military Hospital Abbottabad report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (17)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Hyperpigmentation 5
Melanosis 5
Mite Infestations 2
Molluscum Contagiosum 2
Papillomavirus Infections 2

Trials by start year as sponsor or collaborator (3)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 4
2022 18
2021 4

No forecast is made for this organization: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 25 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (28)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Topical 1 % clotrimazole twice daily 2 weeks Tinea Versicolor Phase 1/2 1
Oral itraconazole 200mg daily for 5 days Tinea Versicolor Phase 1/2 1
Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid Melanosis Phase 1 1
Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid Hyperpigmentation Phase 1 1
Platelets Rich Plasma Hyperpigmentation Phase 1 1

Approved assets (10)

Shown in this order: max phase first.

Approved assets
Drug Trials
Triple combination cream (fluocinolone acetonide + hydroquinone + tretinoin) alone 1
Itraconazole 3
Permethrin 1
Tranexamic Acid 1
Sulphur 1

Journals published in (13)

Shown in this order: most published in first.

Journals published in
Journal Publications
Acta dermatovenerologica Alpina, Pannonica, et Adriatica 1
Anais brasileiros de dermatologia 1
Annals of parasitology 1
Contact dermatitis 1
Dermatology and therapy 1

Latest dated events (26)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-09 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-02-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2022-11-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.